9 Medical Breakthroughs That Gave Us Hope in 2025

Breakthrough 01

A Non-Hormonal Revolution in Menopause Care

More than 80% of women experience hot flashes and night sweats during the transition to menopause, and many report that symptoms are severe enough to impact their daily life. Hormone therapy remains the most effective treatment, but many women cannot take it—especially if they've had breast or uterine cancer, deep vein thrombosis, or other conditions.

Two new non-hormonal treatments for moderate to severe hot flashes now offer relief for those previously left without options. Lynkuet (elinzanetant), approved by the FDA this year, joins Veozah (fezolinetant), which received authorization two years earlier.

The daily pills target temperature-regulating neurons in the brain's hypothalamus, after scientists discovered that these nerve cells are susceptible to the estrogen fluctuations of menopause.

Key Points

80% of women affected
Non-hormonal treatment
FDA approved 2025
Targets hypothalamus
No serious side effects

Breakthrough 02

An Allergy Rescue for Kids Without a Needle

Fast, easy access to epinephrine can be lifesaving for children with severe allergies. This year brought a needle-free alternative. Neffy, a new prescription nasal spray, marks the first major update to epinephrine delivery for children in more than three decades.

Food allergies affect one in 13 kids, and a quick dose of epinephrine during a severe reaction stops the inflammatory chain reaction that could lead to anaphylaxis-related hospitalizations or death. However, many kids—and their caregivers—hesitate to administer an auto-injector such as EpiPen.

Neffy is approved for children ages four and older weighing 33 to 65 pounds. The medicine is absorbed into the body thanks to novel technology that temporarily loosens the space between nasal cells, allowing the drug to be rapidly absorbed into the bloodstream.

Key Points

1 in 13 kids affected
Needle-free nasal spray
Approved from age 4
30-second absorption
First innovation in 30 years

Breakthrough 03

Giant Leaps in Regenerative Medicine

The long-standing sci-fi dream of regenerating or regrowing human body parts edged closer to reality. Scientists studying how amputated salamanders regrow their limbs pinpointed an enzyme that fine-tunes retinoic acid levels, a molecule essential to regeneration.

They also identified a gene that controls appendage size and development. Since humans have the same molecular ingredients, the findings offer a rough blueprint that could one day guide limb regrowth in people recovering from traumatic injuries.

Other advances brought regenerative medicine into new territory. Researchers developed the first implantable patch that strengthened the heart wall in monkeys. Lab-grown stem cells were coaxed to become heart muscle and connective tissue before being implanted and integrated into the heart.

2025 Achievements

Limb regeneration research
Implantable heart patch
Functional ureter tissue
Programmable stem cells
Inspired by salamanders

Breakthrough 04

Better Sexually Transmitted Infection Screens

More than two million Americans are diagnosed annually with a sexually transmitted infection (STI)—but many others have the disease and don't know it. That gap matters: delayed diagnoses and care can cause infertility or chronic pelvic pain, as well as the continued spread of disease.

This year brought significant improvements to how several common STIs are detected. Screening for human papillomavirus (HPV), the STI that can cause cervical cancer, has traditionally involved getting swabbed by a healthcare provider in their office.

A new tool, Teal Wand, lets women collect these vaginal cells at home, after a brief virtual visit to obtain a prescription. Another at-home option, the Visby test, screens for gonorrhea, chlamydia, and trichomoniasis in just 30 minutes.

Innovations

At-home testing available
No prescription needed
Results in 30 minutes
HPV, gonorrhea, chlamydia detection
Greater privacy

Breakthrough 05

Gene Editing for One: Personalized CRISPR Therapy

The gene-editing tool CRISPR-Cas9, which won its inventors the Nobel Prize in 2020, has transformed treatment for conditions such as sickle cell disease. But this year, doctors at the Children's Hospital of Philadelphia used the technology in an unprecedented way.

They designed a custom gene for a single patient—a baby boy born with a rare, life-threatening genetic metabolic disorder. Soon after birth, Baby KJ was diagnosed with a genetic mutation that damaged a crucial enzyme in the urinary system, causing toxic ammonia to dangerously build up in his bloodstream.

About half of infants with this condition die shortly after birth. Doctors identified the genetic flaw and developed a personalized fix, administered to the child at seven and eight months. The CRISPR tool used lipid nanoparticles to ferry genetic instructions to the liver.

Historic Milestone

First individual gene therapy
Nobel Prize CRISPR 2020
Saved baby's life
Lipid nanoparticles delivery
Revolution for rare diseases

Breakthrough 06

Simple, Effective HIV Prevention

Human immunodeficiency virus, the microbe that causes AIDS, remains a major global health challenge. In the United States, more than 100 people are diagnosed daily. Although pre-exposure prophylaxis (PrEP) medications are highly effective, uptake remains low.

Only a third of people in the U.S. who could benefit from PrEP currently take it. This year, the FDA approved a new option that could help close that gap: Yeztugo (lenacapavir), a twice-yearly injectable PrEP developed by Gilead Sciences.

Studies show that, when given every six months, the shots prevent nearly all HIV transmission. The World Health Organization (WHO) calls the approval a "milestone" and notes it will help overcome key barriers such as the need for frequent visits and stigma.

Features

Injection every 6 months
FDA approved 2025
Nearly 100% effective
WHO recognized
No daily stigma

Breakthrough 07

Vaccines That Fight More Than Infection

Vaccines have proven effective tools for protecting against viruses including COVID-19, shingles, flu, and other diseases. But new research shows that these shots may deliver broader benefits, including preventing heart attacks and dementia, and improving patients' response to certain cancer therapy.

People who received the herpes zoster vaccination reduced their risk of stroke by 16% and heart attack by 18%, according to a review of 19 studies. The same shot also lowers the odds of developing dementia by up to a third in the following three years.

Meanwhile, people with advanced lung and skin cancer who received the COVID-19 mRNA vaccine within three months of starting immunotherapy treatment improved the medicine's response to tumors and lived longer.

Surprising Benefits

Reduces stroke risk 16%
Reduces heart attack 18%
Prevents dementia
Improves cancer immunotherapy
Versatile mRNA technology

Breakthrough 08

Stopping Pancreatic Cancer Before It Starts

Pancreatic cancer is one of the deadliest malignancies, in part because it's often diagnosed only after it has reached an advanced stage. Fewer than 13% of patients survive five years after diagnosis.

In 2025, scientists made progress toward detecting—and potentially preventing—the disease much earlier. In studies using lab mice and human cells, scientists found that blocking the FGFR2 protein, which turbocharges early pancreatic cancer cells, prevents them from becoming cancerous in certain situations.

Since drugs that inhibit this protein are already available, researchers hope to test this approach in high-risk individuals, including those with a family history of the disease. Human trials are still needed, but the work offers early insight into how pancreatic cancer might one day be intercepted before it forms.

Key Discovery

FGFR2 protein identified
Prevention before cancer
13% current survival rate
Existing medications available
High family risk focus

Breakthrough 09

Creating an Atlas of the Human Body

Our understanding of the human body took a huge step forward this year when British researchers completed more than one billion medical scans from 100,000 volunteers. The project—part of the U.K. Biobank, one of the world's most comprehensive health databases—includes MRI, ultrasounds, and other detailed scans.

The atlas includes images of the brain, heart, bones, joints, torso, and blood vessels. Researchers also took physical measurements, blood samples, and genetic material, along with assessments of lifestyle and environmental exposures. All data has been anonymized.

The next step is for several hundred thousand participants to return up to seven years later for additional scans, providing evidence of how the body changes over time. The biobank has already powered thousands of scientific studies, revealing surprising connections between cardiovascular and brain health.

Project Data

100,000 volunteers
1 billion scans completed
U.K. Biobank project
7-year follow-up
Thousands of studies derived

9 Medical Breakthroughs
That Gave Us Hope

From personalized gene therapies to early cancer detection

A Non-Hormonal Revolution in Menopause Care